Bleakley Financial Group »

Vertex Pharmaceuticals Incorporated shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $13M 27k 468.72
2024-03-31 $12M 28k 418.01
2023-12-31 $9.1M 22k 406.89
2023-09-30 $6.4M 19k 347.74
2023-06-30 $6.2M 18k 351.91
2023-03-31 $2.5M 8.0k 315.07
2022-12-31 $2.2M 7.5k 288.78

More positions owned by Bleakley Financial Group

Vanguard Index Fds Large Cap Etf (VV)
Sprott Physical Gold & Silve Tr Unit (CEF)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Sprott Physical Gold Tr Unit (PHYS)
NVIDIA Corporation (NVDA)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Eli Lilly & Co. (LLY)

View all positions for Bleakley Financial Group

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Capital Research Global Investors
Jennison Associates
Wellington Management Company
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services

View all funds holding Vertex Pharmaceuticals Incorporated